MRI-guided treatment of liver tumours with radioactive microspheres

Tuesday 24 November 2026, 2:30 pm
MRI-guided holmium-166 transarterial radioembolization: Technical advancements and clinical considerations
PhD candidate
M.W.M. van Wijk
Promotor(s)
dr. J.F.W. Nijsen, prof. dr. ir. T.W.J. Scheenen
Co-promotor(s)
dr. J. Roosen, dr. E.T.T.L. Tjwa
Location
Aula

Transarterial radioembolization (TARE) is a treatment in which radioactive microspheres are injected through the hepatic artery to deliver localized radiation to the liver. The aim is to deliver a sufficient dose to the tumour while sparing healthy liver tissue.

This thesis demonstrates that MRI-guided, adaptive TARE offers opportunities to improve treatment. A novel MRI quantification method enabled more accurate assessment of microsphere distribution and radiation dose during treatment. An administration system was developed to precisely control the amount of microspheres delivered. Research into microsphere distribution within tumours highlighted the importance of achieving a homogeneous radiation dose. Important insights were also gained into potential lung injury following treatment.

In a first clinical study, four patients with primary liver cancer received a higher radiation dose using MRI-guided TARE than with conventional treatment, without experiencing severe adverse events. These results support further development of personalized radioembolization. 

Meike van Wijk (1996) is a technical physician and postdoctoral researcher at Radboudumc. She obtained her bachelor’s and master’s degrees in Technical Medicine from the University of Twente (2021). Her PhD research focused on MRI-guided holmium-166 transarterial radioembolization (TARE). She is also program coordinator of NUCMED-NL and involved in national projects promoting innovation, collaboration, and education in nuclear medicine.